Formycon and its commercialization partner Fresenius Kabi have announced that the US Food and Drug Administration (FDA) has ...

Markets expect rate cuts — but your earnings don’t have to suffer. Lock in 7.2% until 2028 from ten individual bonds. Based ...

The current earnings multiple is quite low if you take out non-recurring items (NRI). The company now has two operating engines after spinning off consumer brand Kenvue in 2023. Those businesses ...

Uncertainty continues to grip markets as the Donald Trump administration signals a potential return to aggressive trade ...

Cramer noted that investors are skirting Johnson & Johnson (NYSE:JNJ) because of worries regarding Robert Kennedy Jr., as he ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Following a third failed bankruptcy maneuver by Johnson & Johnson (NYSE: JNJ), trial lawyers with Dallas-based Nachawati Law Group have filed three new lawsuits on behalf of women who developed cancer ...

Johnson & Johnson is a dividend king stock whose strong product line and consistency has earned it a listing on the Dow Jones ...

We recently published a list of 13 Best Cheap Stocks to Invest in for Beginners. In this article, we are going to take a look ...

Johnson & Johnson (NYSE:JNJ) receives a stock grade upgrade to “Buy” by Johnson Rice. The company is scheduled to participate ...

A month has gone by since the last earnings report for Johnson & Johnson (JNJ). Shares have lost about 4.9% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...